AORT

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Artivion Inc

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
CEO
James Mackin
Employees
1200
Headquarters

1655 Roberts Blvd NW
Kennesaw, Georgia 30144-3632
Phone: 17704193355
www.cryolife.com

News

Artivion to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Mar 06, 2023 21:10pm

ATLANTA, March 6, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 33rd Annual Healthcare Conference. The Company''s virtual fireside…


Source:PR Newswire
Massive Insider Trade At Artivion
Mar 02, 2023 15:02pm

James P Mackin , President & CEO at Artivion (NYSE: AORT ), reported a large insider sell on March 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Mackin sold 22,630 shares of Artivion . The total transaction amounted to $292,786. Artivion shares are trading down 0.69% at $12.95 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com


Source:Benzinga
Why Artivion Stock Popped on Friday
Feb 18, 2023 00:31am

There''s nothing like an upside earnings surprise to juice the price of a company''s shares.


Source:The Motley Fool
Why Artivion Stock Popped Today
Feb 18, 2023 00:31am

There''s nothing like an upside earnings surprise to juice the price of a company''s shares.


Source:The Motley Fool
Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M
Feb 16, 2023 21:24pm

Artivion press release (AORT): Q4 Non-GAAP EPS of $0.10 beats by $0.12.Revenue of $79.4M (flat Y/Y) misses by $0.77M.Full Year 2022 Financial ResultsTotal revenues for 2022 were…


Source:Seeking Alpha
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results
Feb 02, 2023 13:30pm

ATLANTA, Feb. 2, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2022 financial results will be released on Thursday, February 16, 2023 after the market closes. On…


Source:PR Newswire